Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G-Y Lai

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|October 15, 2014
Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC studyG Y Lai, S J Weinstein, P R Taylor, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 5, 2012
Enhancing a cancer prevention and control curriculum through interactive group discussionsL P Forsythe, S M Gadalla, J G Hamilton, et al.
JTO Clinical and Research Reports|January 1, 2024
Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate MeasureStephanie P L Saw, Gek San Tan, Wei Chong Tan, et al.
Human Genomics|July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerNing-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2025
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancerStephanie P L Saw, Angela Takano, Siqin Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2022
PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancerStephanie P L Saw, Win Pin Ng, Siqin Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2024
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLCStephanie P L Saw, Yi Fen Low, Gillianne G Y Lai, et al.
JCO Precision Oncology|October 14, 2022
Clinical and Genomic Features of <i>HER2</i> Exon 20 Insertion Mutations and Characterization of <i>HER2</i> Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung CancerAaron C Tan, Stephanie P L Saw, Jianbin Chen, et al.
Cancer|February 29, 2024
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancerAaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|October 15, 2014
Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC studyG Y Lai, S J Weinstein, P R Taylor, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 5, 2012
Enhancing a cancer prevention and control curriculum through interactive group discussionsL P Forsythe, S M Gadalla, J G Hamilton, et al.
JTO Clinical and Research Reports|January 1, 2024
Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate MeasureStephanie P L Saw, Gek San Tan, Wei Chong Tan, et al.
Human Genomics|July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerNing-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2025
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancerStephanie P L Saw, Angela Takano, Siqin Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2022
PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancerStephanie P L Saw, Win Pin Ng, Siqin Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2024
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLCStephanie P L Saw, Yi Fen Low, Gillianne G Y Lai, et al.
JCO Precision Oncology|October 14, 2022
Clinical and Genomic Features of <i>HER2</i> Exon 20 Insertion Mutations and Characterization of <i>HER2</i> Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung CancerAaron C Tan, Stephanie P L Saw, Jianbin Chen, et al.
Cancer|February 29, 2024
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancerAaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Pageof 3